Highlighting concerns with the pharmaceutical supply chain, the Food and Drug Administration warned McKesson (MCK), one of the nation’s largest wholesalers, for failing to properly handle episodes where pharmacies received tampered medicines, including three instances in which bottles contained naproxen instead of oxycodone, the highly addictive painkiller.

Specifically, the agency found that McKesson responded inadequately and demonstrated a lack of understanding of key regulations, according to a Feb. 7 warning letter. Notably, the letter is the first such missive issued under the Drug Supply Chain Security Act and also figured prominently in fresh remarks Tuesday by FDA Commissioner Scott Gottlieb about the ongoing opioid crisis.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • This was only acted on, becuse it was an opiate that was stolen from the supply chain. These malicious actors are usually not this inept. Other drug repalcemtns would not have gotten a second glance.

  • Fines should be set as # of days of GROSS REVENUES, eg, 10 days or 30days or in case of major harm or death, in years or even disincorporation…
    After all, if corporations are “persons”, then let the CEOs serve thetime along with the fines!!

  • $150 million is peanuts, McKesson should be held liable, criminally for prescription opioid overdose deaths as well as ruined lives from substance use disorder.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy